Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Leo Pharma
Pharma
Leo increases sales in US and bumps up 2025 revenue guidance
Leo reported that sales of eczema treatment Adbry are scaling up in the U.S. The company also made a positive adjustment to its 2025 sales guidance.
Kevin Dunleavy
Aug 19, 2025 12:38pm
FDA signs off on Leo Pharma's chronic hand eczema cream Anzupgo
Jul 24, 2025 8:45am
UK watchdog scolds Leo Pharma's slow response to app lapse
Jul 17, 2025 10:15am
Leo ponies up €90 million for Boehringer Ingelheim's Spevigo
Jul 14, 2025 8:25am
Leo survey shows chronic hand eczema’s effects on patient lives
Apr 22, 2025 6:00am
Leo Pharma finds derms want better chronic hand eczema meds
Mar 5, 2025 1:07pm
